MyPharmacy+

Introduction:

In Treatment of Bacterial eye infections SB Moxi 0.5% Eye Drop is an antibiotic medicine. It works by stopping the growth of the bacteria that is causing the infection. It helps relieve symptoms such as pain redness itching or soreness caused due to eye infections. The dose and duration of treatment will be decided by your doctor based on your condition. Make sure you complete the full course of treatment. This will ensure that the infection is completely cured and prevent it from returning.

How to use:

This medicine is for external use only. Use it in the dose and duration as advised by your doctor. Check the label for directions before use. Hold the dropper close to the eye without touching it. Gently squeeze the dropper and place the medicine inside the lower eyelid. Wipe off the extra liquid.

Description:

SB Moxi 0.5% Eye Drop is an antibiotic used in the treatment of bacterial infections of the eye. It relieves the symptoms of the infection by stopping the further growth of the causative microorganisms.SB Moxi 0.5% Eye Drop is for external use only. Take it in the dose and duration as advised by your doctor. Hold the dropper close to the eye without touching it. Gently squeeze the dropper and place the medicine inside the lower eyelid. Wipe off extra liquid. Avoid skipping any doses and finish the full course of treatment even if you feel better.It may cause eye discomfort dry eyes and burning sensation in the eyes immediately following application. However these side effects are temporary and usually subside on their own. Inform your doctor if they persist for a longer duration. It may cause short term blurring of vision when first used. Use caution before driving or using machines. Do not wear contact lenses while using it.

Benefits:

This medicine is for external use only. Use it in the dose and duration as advised by your doctor. Check the label for directions before use. Hold the dropper close to the eye without touching it. Gently squeeze the dropper and place the medicine inside the lower eyelid. Wipe off the extra liquid.

Safety Advise:

- Alcohol : None No interaction found/established | - Pregnancy : CONSULT YOUR DOCTOR SB Moxi 0.5% Eye Drop may be unsafe to use during pregnancy. Although there are limited studies in humans animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor. | - Breast feeding : CONSULT YOUR DOCTOR SB Moxi 0.5% Eye Drop is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. | - Driving : UNSAFE SB Moxi 0.5% Eye Drop may cause side effects which could affect your ability to drive.SB Moxi 0.5% Eye Drop may make you feel dizzy or light-headed you may experience a sudden transient loss of vision or you may faint for a short period. This may affect your driving ability. | - Kidney : None No interaction found/established | - Liver : None No interaction found/established

If you miss a dose:

If you miss a dose of SB Moxi 0.5% Eye Drop use it as soon as possible. However if it is almost time for your next dose skip the missed dose and go back to your regular schedule. Do not double the dose.

Fact Box:

Chemical Class :: Fluoroquinolone|Habit Forming :: No|Therapeutic Class :: OPHTHAL

SB Moxi 0.5% Eye Drop

Manufactured By S.Bee Life Sciences

Salt Composition Moxifloxacin (0.5% w/v)

Rs. 118.75

MRP 125.00

Includes all taxes

Package SIZE

Available Substitutes

4 Quin 0.5% Eye Gel

Entod Pharmaceuticals Ltd

4 Quin Eye Drop

Entod Pharmaceuticals Ltd

4 Quin Ophthalmic Solution

Entod Pharmaceuticals Ltd

4Flox 0.5% Eye Drop

Eryx Biotech

Opomox Eye Drop

Medivaxia Pharma

Uses / Indications:

Introduction:

How to use:

Description:

Benefits:

Safety Advise:

If you miss a dose:

Fact Box:

Primary Use:

Common Side Effects:

Alcohol Interaction:

Pregnancy Interaction:

Lactation Interaction:

Driving Interaction:

Kidney Interaction:

Liver Interaction:

Q&A: